SAN DIEGO, Dec. 3, 2025 /PRNewswire/ -- Sanguine Biosciences, a leading provider of high-quality human biospecimens and real-world clinical data, today announced the expansion of its clinical sample ...
Nine statements developed, including performing 4 or more vs 3 or fewer needle passes in suspected malignant disease. HealthDay News — In a new clinical guideline issued by the American College of ...
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion–Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting We evaluated the clinical ...
Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial. Continuous MMAI scores ...
GCCL and OPIS sign MoU to advance global clinical trial capabilities: South Korea Friday, January 16, 2026, 13:00 Hrs [IST] GCCL, a leading South Korea-based provider of clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results